Why the study?
Does neoadjuvant chemoradiation therapy influence postoperative morbidity and mortality in patients with lower and medium rectal cancer?
Population
42 patients who underwent elective surgical resection for lower and medium rectal cancer
Comparison
Neoadjuvant chemoradiation therapy and… vs Primary surgical treatment
Design
Cohort
Follow-up
30-day
Authors
Loading...
Neoadjuvant chemoradiation therapy prior to rectal cancer surgery does not significantly increase postoperative morbidity or mortality compared to primary surgery.
Does neoadjuvant chemoradiation therapy influence postoperative morbidity and mortality in patients with lower and medium rectal cancer?
Neoadjuvant chemoradiation therapy prior to rectal cancer surgery does not significantly increase postoperative morbidity or mortality compared to primary surgery.
Ugolini et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: